<DOC>
	<DOCNO>NCT00804726</DOCNO>
	<brief_summary>The objective 12-month clinical investigation evaluate safety effectiveness Bausch &amp; Lomb Akreos MI Five-O intraocular lens ( IOL ) . Effectiveness show demonstration accurate distance correction safety demonstrate monitoring adverse event .</brief_summary>
	<brief_title>Evaluation Safety Effectiveness Akreos MI Five-0 Intraocular Lens .</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<criteria>Subjects must clinically document diagnosis agerelated cataract . Subjects must clear intraocular medium cataract . Subjects must undergo primary inthebag intraocular lens implantation correction aphakia follow continuous curvilinear anterior capsulotomy phacoemulsification cataract extraction . Subjects anterior segment pathology extracapsular phacoemulsification cataract surgery would contraindicate . Subjects diagnosis degenerative visual disorder . Subjects inflammation edema ( swell ) cornea . Subjects immunodeficiency disorder . Subjects previous intraocular surgery study eye . Subjects incomplete/damaged zonule , condition associate increase risk zonular rupture . Subjects chronic use systemic steroid immunosuppressive medication .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Cataract extraction</keyword>
	<keyword>Phacoemulsification</keyword>
</DOC>